Making artificial antibodies: a format for phage display of combinatorial heterodimeric arrays
about
Expanding the versatility of phage display II: improved affinity selection of folded domains on protein VII and IX of the filamentous phageMolecular immunolabeling with recombinant single-chain variable fragment (scFv) antibodies designed with metal-binding domainsBeyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold.Efficient phage display of polypeptides fused to the carboxy-terminus of the M13 gene-3 minor coat protein.Selective infection of E. coli as a function of a specific molecular interaction.A method for the generation of combinatorial antibody libraries using pIX phage displayMonoclonal antibody therapy for central nervous system lymphomas: an emerging treatment paradigm.A comprehensive analysis of filamentous phage display vectors for cytoplasmic proteins: an analysis with different fluorescent proteins.Synthetic phage for tissue regenerationExpanding the versatility of phage display I: efficient display of peptide-tags on protein VII of the filamentous phage.Membrane insertion and assembly of epitope-tagged gp9 at the tip of the M13 phage.Molecular considerations for development of phage antibody libraries.DeltaPhage--a novel helper phage for high-valence pIX phagemid display.Toward cocaine esterase therapeuticsDetection of biomarkers using recombinant antibodies coupled to nanostructured platformsImmobilization techniques for microarray: challenges and applicationsSimultaneous display of two large proteins on the head and tail of bacteriophage lambdaOligopeptide m13 phage display in pathogen research.Phage display selection of tight specific binding variants from a hyperthermostable Sso7d scaffold protein library.Protein-detecting microarrays: current accomplishments and requirements.Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy.Evolution of phage display technology: from discovery to application.Multiplex approaches in protein microarray technology.Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy.Genome-scale functional profiling of the mammalian AP-1 signaling pathway.M13 bacteriophage display framework that allows sortase-mediated modification of surface-accessible phage proteinsTreating cocaine addiction with virusesDirected evolution of streptavidin variants using in vitro compartmentalization.Design of virus-based nanomaterials for medicine, biotechnology, and energy.Multivalent pIX phage display selects for distinct and improved antibody properties.Directed surface attachment of nanomaterials via coiled-coil-driven self-assembly.Development of efficient RNA interference system using EGF-displaying phagemid particles.A tractable method for simultaneous modifications to the head and tail of bacteriophage lambda and its application to enhancing phage-mediated gene delivery.Site directed biotinylation of filamentous phage structural proteinsTranslocation Pathway-Dependent Assembly of Streptavidin- and Antibody-Binding Filamentous Virus-Like Particles.Generation, characterization, and docking studies of DNA-hydrolyzing recombinant F(ab) antibodies.Enhancement of the enzymatic activity of activated coagulation factor IX by anti-factor IX antibodies.Pericyte modulation by a functional antibody obtained by a novel single-cell selection strategy.Generating FN3-Based Affinity Reagents Through Phage Display
P2860
Q21135530-3B417CCF-C110-4DA3-B807-81CBB62B81E3Q24531284-82991374-12C4-4A93-99D1-F2315A5108F7Q26795483-993DFC5C-256A-4F81-812D-E8EBD4F1AA74Q30658774-603A9AF9-B53E-48E1-BAC2-E2E193E1E17AQ32064624-C503723D-C83C-431E-90A0-10AED4EF2D91Q33184414-4A96013B-6B8D-412E-8E96-833149515E30Q33217186-BF68AD7D-1743-47F6-AD4B-926E85DB71A8Q33700201-0DE0C7E9-49F2-4CED-9384-212DE2A00F65Q33758770-69F65556-2B15-4843-85FE-6BD959E153A0Q33841982-598980AF-C7A1-4640-814C-F9DD6D27581FQ34028984-5B1B3359-66E3-49A3-B3B0-92627349E89CQ34032165-BFF71151-9C23-41F7-A8CE-A82B7FF848B9Q34249101-4DDF161B-49F9-47E3-B80F-8C6D1F00D1F2Q34316392-07C844AA-2DE1-45EB-872E-DC960EA52BDCQ34352221-8E0C7B53-AEBE-4875-8457-8999BAC89565Q34984821-8CFFAFFB-4D8B-429C-86D3-3928EE0A86F8Q35001176-08100B0B-1BB3-4C1D-A5B1-0E61157E31BCQ35020004-F80ED75D-82DE-4759-ABAF-00F4B4D005B8Q35911849-A41B65C9-1BB4-45EA-B03B-87698BD1589AQ36080618-48A73049-71E8-41DF-BDE3-57732C1FF637Q36161215-1C26DDEA-D125-4C99-A4EC-507570C23818Q36183954-7E66BED7-05C0-4718-893B-7BEE4179BA12Q36227932-9B6CEADF-E3B8-49A4-B349-4A7FEECC9161Q36341673-CF61904B-FAE9-42B8-8A7E-2B83B0A56089Q36348665-2AAC1E16-C900-455D-BA5A-2D699488F1AEQ36588148-B65C1500-05D6-40A9-9217-2B7CDF202DA0Q36672225-DEF33B37-615C-4AE1-91EA-68907D4331FAQ37041529-52029BE2-0AC4-493A-A9CF-A018B19888F4Q37346447-79D80A58-AE2D-4F16-A13A-F11184B07BA2Q37501464-1C70EB95-5779-40C1-8531-282C22CC7A16Q38897172-0EEB8FB9-8B15-4864-84A5-452BBF3815AAQ39999801-02E2CE63-A7D4-4591-89E7-443AD3928BEFQ40152980-FB5C03CF-8553-4475-86D7-6D9AA906CE33Q40329257-3A9E1CFC-8B35-4A03-9D45-3ABE682EE1CBQ40529713-942A150E-1AF6-47A4-A261-D9E0BE4E756AQ42798552-56BA8D4A-CFA3-4C76-8250-5017AAAD3D32Q45873800-EFAF6F67-8AE9-40DA-B3B4-8BED83ABD031Q48194510-53BC98E5-9F53-438E-B3B3-4F1F73B2AA4BQ56889298-5684C5E8-7329-4513-B258-32224C321488
P2860
Making artificial antibodies: a format for phage display of combinatorial heterodimeric arrays
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Making artificial antibodies: ...... inatorial heterodimeric arrays
@ast
Making artificial antibodies: ...... inatorial heterodimeric arrays
@en
Making artificial antibodies: ...... inatorial heterodimeric arrays
@nl
type
label
Making artificial antibodies: ...... inatorial heterodimeric arrays
@ast
Making artificial antibodies: ...... inatorial heterodimeric arrays
@en
Making artificial antibodies: ...... inatorial heterodimeric arrays
@nl
prefLabel
Making artificial antibodies: ...... inatorial heterodimeric arrays
@ast
Making artificial antibodies: ...... inatorial heterodimeric arrays
@en
Making artificial antibodies: ...... inatorial heterodimeric arrays
@nl
P2093
P2860
P356
P1476
Making artificial antibodies: ...... inatorial heterodimeric arrays
@en
P2093
P2860
P304
P356
10.1073/PNAS.96.11.6025
P407
P577
1999-05-25T00:00:00Z